Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors

被引：0

作者：

Chen, Po-Han ^{[1
]}

Bossuyt, Veerle ^{[2
]}

Reisenbichler, Emily ^{[1
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] Massachusetts Gen Hosp, Woodbridge, CT USA

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

123

引用

页数：2

共 50 条

[31] The Utility of Lymphoid Enhancer Binding Factor 1 (LEF1) and Androgen Receptor (AR) in Diagnosing Solid Pseudopapillary Neoplasm (SPN) of Pancreas on Cytopathology [J].

Policarpio-Nicolas, Maria Luisa ;

Stelow, Edward ;

Harrison, Grant ;

McHugh, Kelsey .

LABORATORY INVESTIGATION, 2019, 99

[32] β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway [J].

Zhou, A-D ;

Diao, L-T ;

Xu, H. ;

Xiao, Z-D ;

Li, J-H ;

Zhou, H. ;

Qu, L-H .

ONCOGENE, 2012, 31 (24) :2968-2978

[33] The Utility of Lymphoid Enhancer Binding Factor 1 (LEF1) and Androgen Receptor (AR) in Diagnosing Solid Pseudopapillary Neoplasm (SPN) of Pancreas on Cytopathology [J].

Policarpio-Nicolas, Maria Luisa ;

Stelow, Edward ;

Harrison, Grant ;

McHugh, Kelsey .

MODERN PATHOLOGY, 2019, 32

[34] The plant sesquiterpene lactone parthenolide inhibits Wnt/beta-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1 [J].

Zhu, Xiaoliang ;

Yuan, Chunmao ;

Tian, Chenyang ;

Li, Chen ;

Nie, Fen ;

Song, Xiaomin ;

Zeng, Rong ;

Wu, Dianqing ;

Hao, Xiaojiang ;

Li, Lin .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (14) :5335-5344

[35] LOW EXPRESSION OF LYMPHOID ENHANCER-BINDING FACTOR-1 (LEF1) ASSOCIATES WITH POOR PROGNOSTIC FACTORS IN PEDIATRIC ACUTE LEUKEMIA [J].

Malatesta, R. ;

Vega-Garcia, N. ;

Estella, C. ;

Rives, S. ;

Torrebadell, M. ;

Catala, A. ;

Berrueco, R. ;

Ruiz-Llobet, A. ;

Calvente, L. ;

Trabazo, M. ;

Alonso-Saladrigues, A. ;

Mesegue, M. ;

Solsona, M. ;

Camos, M. .

HAEMATOLOGICA, 2016, 101 :355-355

[36] β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway [J].

A-D Zhou ;

L-T Diao ;

H Xu ;

Z-D Xiao ;

J-H Li ;

H Zhou ;

L-H Qu .

Oncogene, 2012, 31 :2968-2978

[37] High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia [J].

Metzeler, Klaus H. ;

Heilmeier, Bernhard ;

Edmaier, Katrin E. ;

Rawat, Vijay P. S. ;

Dufour, Annika ;

Doehner, Konstanze ;

Feuring-Buske, Michaela ;

Braess, Jan ;

Spiekermann, Karsten ;

Buechner, Thomas ;

Sauerland, Maria C. ;

Doehner, Hartmut ;

Hiddemann, Wolfgang ;

Bohlander, Stefan K. ;

Schlenk, Richard F. ;

Bullinger, Lars ;

Buske, Christian .

BLOOD, 2012, 120 (10) :2118-2126

[38] HLA CLASS I ANTIBODIES INCREASED WNT/B-CATENIN PATHWAY COMPONENT PROTEIN LYMPHOID-BINDING FACTOR 1 (LEF1) IN ENDOTHELIAL CELLS IN FOXO1 PROTEIN DEPENDENT FASHION. [J].

Twombley, K. ;

Kavarana, M. ;

Savage, A. ;

Moussa, O. .

PEDIATRIC TRANSPLANTATION, 2017, 21 :43-43

[39] Blockade of Beta-Catenin/ALDH1 Axis Suppresses Progression and Metastasis of Osteosarcoma: Preclinical Study of a Novel WNT/Beta-Catenin Pathway Inhibitor Tegavivint [J].

Nomura, M. ;

Rainusso, N. ;

Yustein, J. .

PEDIATRIC BLOOD & CANCER, 2018, 65 :S421-S422

[40] In human endothelial cell line Wnt-beta-catenin pathway controls transcription of lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family enhancing matrix metalloproteinase-2 transcription and endothelial cell invasion [J].

Planutiene, Marina ;

Planutis, Kestutis ;

Holcombe, Randall F. .

CANCER RESEARCH, 2012, 72

← 1 2 3 4 5 →